Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 82

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein

Laptenko, Oleg, Tong, David R., Manfredi, James, Prives, Carol·2016·Trends in Biochemical Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2016.08.011

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 87

  1. Belyi, 2010, The origins and evolution of the p53 family of genes, Cold Spring Harb. Perspect. Biol, 2, a001198, 10.1101/cshperspect.a001198 · DOI · Paper page
  2. Laptenko, 2006, Transcriptional regulation by p53: one protein, many possibilities, Cell Death Differ., 13, 951, 10.1038/sj.cdd.4401916 · DOI · Paper page
  3. Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
  4. Lee, 2000, Transcription of eukaryotic protein-coding genes, Annu. Rev. Genet., 34, 77, 10.1146/annurev.genet.34.1.77 · DOI · Paper page
  5. Joerger, 2008, Structural biology of the tumor suppressor p53, Annu. Rev. Biochem., 77, 557, 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
  6. Foord, 1991, A DNA binding domain is contained in the C-terminus of wild type p53 protein, Nucleic Acids Res., 19, 5191, 10.1093/nar/19.19.5191 · DOI
  7. Vogelstein, 1992, p53 function and dysfunction, Cell, 70, 523, 10.1016/0092-8674(92)90421-8 · DOI · Paper page
  8. Ahn, 2001, The C-terminus of p53: the more you learn the less you know, Nat. Struct. Biol., 8, 730, 10.1038/nsb0901-730 · DOI
  9. Bell, 2002, p53 contains large unstructured regions in its native state, J. Mol. Biol., 322, 917, 10.1016/S0022-2836(02)00848-3 · DOI · Paper page
  10. Cheng, 2007, Mining alpha-helix-forming molecular recognition features with cross species sequence alignments, Biochemistry, 46, 13468, 10.1021/bi7012273 · DOI · Paper page
  11. Friedler, 2005, Modulation of binding of DNA to the C-terminal domain of p53 by acetylation, Structure, 13, 629, 10.1016/j.str.2005.01.020 · DOI · Paper page
  12. Xue, 2013, Intrinsically disordered regions of p53 family are highly diversified in evolution, Biochim. Biophys. Acta, 1834, 725, 10.1016/j.bbapap.2013.01.012 · DOI
  13. Tompa, 2015, Intrinsically disordered proteins: emerging interaction specialists, Curr. Opin. Struct. Biol., 35, 49, 10.1016/j.sbi.2015.08.009 · DOI · Paper page
  14. Brown, 2011, Evolution and disorder, Curr. Opin. Struct. Biol., 21, 441, 10.1016/j.sbi.2011.02.005 · DOI · Paper page
  15. Rustandi, 2000, Structure of the negative regulatory domain of p53 bound to S100B(betabeta), Nat. Struct. Biol., 7, 570, 10.1038/76797 · DOI
  16. Mujtaba, 2004, Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation, Mol. Cell., 13, 251, 10.1016/S1097-2765(03)00528-8 · DOI · Paper page
  17. Tong, 2015, Structural plasticity of methyllysine recognition by the tandem tudor domain of 53BP1, Structure, 23, 312, 10.1016/j.str.2014.11.013 · DOI · Paper page
  18. Tong, 2015, An acetyl–methyl switch drives a conformational change in p53, Structure, 23, 10.1016/j.str.2014.12.010 · DOI · Paper page
  19. Boehme, 2009, Regulation of p53 – insights into a complex process, Crit. Rev. Biochem. Mol. Biol., 44, 367, 10.3109/10409230903401507 · DOI
  20. Brooks, 2011, The impact of acetylation and deacetylation on the p53 pathway, Protein Cell, 2, 456, 10.1007/s13238-011-1063-9 · DOI · Paper page
  21. Dos Santos, 2016, Functional diversification after gene duplication: paralog specific regions of structural disorder and phosphorylation in p53, p63, and p73, PLoS ONE, 11, e0151961, 10.1371/journal.pone.0151961 · DOI
  22. Maisse, 2003, p73 and p63 protein stability: the way to regulate function?, Biochem. Pharmacol., 66, 1555, 10.1016/S0006-2952(03)00511-2 · DOI
  23. Zdzalik, 2010, Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73, Cell Cycle, 9, 4584, 10.4161/cc.9.22.13871 · DOI
  24. McKinney, 2004, p53 linear diffusion along DNA requires its C terminus, Mol. Cell, 16, 413, 10.1016/j.molcel.2004.09.032 · DOI · Paper page
  25. Tafvizi, 2008, Tumor suppressor p53 slides on DNA with low friction and high stability, Biophys. J., 95, L01, 10.1529/biophysj.108.134122 · DOI · Paper page
  26. Tafvizi, 2011, A single-molecule characterization of p53 search on DNA, Proc. Natl. Acad. Sci. U.S.A., 108, 563, 10.1073/pnas.1016020107 · DOI · Paper page
  27. Khazanov, 2011, Sliding of p53 along DNA can be modulated by its oligomeric state and by cross-talks between its constituent domains, J. Mol. Biol., 408, 335, 10.1016/j.jmb.2011.01.059 · DOI
  28. Vuzman, 2012, Intrinsically disordered regions as affinity tuners in protein–DNA interactions, Mol. Biosyst., 8, 47, 10.1039/C1MB05273J · DOI · Paper page
  29. Murata, 2015, One-dimensional sliding of p53 along DNA is accelerated in the presence of Ca2+ or Mg2+ at millimolar concentrations, J. Mol. Biol., 427, 2663, 10.1016/j.jmb.2015.06.016 · DOI
  30. McKinney, 2002, Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein, Mol. Cell. Biol., 22, 6797, 10.1128/MCB.22.19.6797-6808.2002 · DOI
  31. Göhler, 2002, Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain, J. Biol. Chem., 277, 41192, 10.1074/jbc.M202344200 · DOI
  32. Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
  33. Palecek, 2004, Enhancement of p53 sequence-specific binding by DNA supercoiling, Oncogene, 23, 2119, 10.1038/sj.onc.1207324 · DOI
  34. Kim, 2012, p53 requires an intact C-terminal domain for DNA binding and transactivation, J. Mol. Biol., 415, 843, 10.1016/j.jmb.2011.12.001 · DOI · Paper page
  35. Brázda, 2011, Cruciform structures are a common DNA feature important for regulating biological processes, BMC Mol. Biol., 5, 12
  36. Alvarez, 2003, Context-dependent transcription: all politics is local, Gene, 313, 43, 10.1016/S0378-1119(03)00627-9 · DOI
  37. Laptenko, 2015, The p53C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain, Mol. Cell, 57, 1034, 10.1016/j.molcel.2015.02.015 · DOI · Paper page
  38. Lidor, 2010, p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy, Genome Res., 20, 1361, 10.1101/gr.103945.109 · DOI
  39. Sammons, 2015, TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activity, Genome Res., 25, 179, 10.1101/gr.181883.114 · DOI
  40. Laptenko, 2011, p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation, Proc. Natl. Acad. Sci. U.S.A., 108, 10385, 10.1073/pnas.1105680108 · DOI
  41. Hamard, 2012, p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes, J. Biol. Chem., 287, 22397, 10.1074/jbc.M111.331298 · DOI · Paper page
  42. Mougiakos, 2016, Next generation prokaryotic engineering: the CRISPR-Cas toolkit, Trends Biotechnol., 34, 575, 10.1016/j.tibtech.2016.02.004 · DOI
  43. Boettcher, 2015, Choosing the right tool for the job: RNAi, TALEN, or CRISPR, Mol. Cell, 58, 575, 10.1016/j.molcel.2015.04.028 · DOI · Paper page
  44. Ayed, 2001, Latent and active p53 are identical in conformation, Nat. Struct. Biol., 8, 756, 10.1038/nsb0901-756 · DOI
  45. D’Abramo, 2016, The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain, Oncogene, 35, 3272, 10.1038/onc.2015.388 · DOI · Paper page
  46. Marcel, 2011, Biological functions of p53 isoforms through evolution: lessons from animal and cellular models, Cell Death Differ., 18, 1815, 10.1038/cdd.2011.120 · DOI · Paper page
  47. Marcel, 2014, Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response, Cell Death Differ., 21, 1377, 10.1038/cdd.2014.73 · DOI
  48. Silden, 2013, Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53null cell lines, PLoS ONE, 8, e56276, 10.1371/journal.pone.0056276 · DOI
  49. Rippin, 2002, Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding, J. Mol. Biol., 319, 351, 10.1016/S0022-2836(02)00326-1 · DOI · Paper page
  50. Kitayner, 2006, Structural basis of DNA recognition by p53 tetramers, Mol. Cell, 22, 741, 10.1016/j.molcel.2006.05.015 · DOI · Paper page
  51. Petty, 2011, An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity, EMBO J., 30, 2167, 10.1038/emboj.2011.127 · DOI · Paper page
  52. Okorokov, 2006, The structure of p53 tumor suppressor protein reveals the basis for its functional plasticity, EMBO J., 25, 5191, 10.1038/sj.emboj.7601382 · DOI · Paper page
  53. Melero, 2011, Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA, Proc. Natl. Acad. Sci. U.S.A., 108, 557, 10.1073/pnas.1015520107 · DOI · Paper page
  54. Wu, 2016, Visualizing the path of DNA through proteins using DREEM imaging, Mol. Cell, 61, 315, 10.1016/j.molcel.2015.12.012 · doi:10.1016/j.molcel.2015.12.012
  55. Nudler, 1998, Spatial organization of transcription elongation complex in Escherichia coli, Science, 281, 424, 10.1126/science.281.5375.424 · DOI
  56. Parshin, 2015, DksA regulates RNA polymerase in Escherichia coli through a network of interactions in the secondary channel that includes Sequence Insertion 1, Proc. Natl. Acad. Sci. U.S.A., 112, E6862, 10.1073/pnas.1521365112 · DOI
  57. Arlt, 2015, Structure of full-length p53 tumor suppressor probed by chemical cross-linking and mass spectrometry, Proteomics, 15, 2746, 10.1002/pmic.201400549 · DOI
  58. Gu, 2012, Surf the post-translational modification network of p53 regulation, Int. J. Biol. Sci., 8, 672, 10.7150/ijbs.4283 · DOI · Paper page
  59. Meek, 2009, Posttranslational modification of p53: cooperative integrators of function, Cold Spring Harb. Perspect. Biol., 1, a000950, 10.1101/cshperspect.a000950 · DOI · Paper page
  60. Kruse, 2008, SnapShot: p53 posttranslational modifications, Cell, 133, 930, 10.1016/j.cell.2008.05.020 · DOI · Paper page
  61. Pant, 2014, Limiting the power of p53 through the ubiquitin proteasome pathway, Genes Dev., 28, 1739, 10.1101/gad.247452.114 · DOI · Paper page
  62. Poyurovsky, 2010, The C terminus of p53 binds the N-terminal domain of MDM2, Nat. Struct. Mol. Biol., 17, 982, 10.1038/nsmb.1872 · DOI
  63. Simeonova, 2013, Mutant mice lacking the p53 C-terminal domain model telomere syndromes, Cell Rep., 3, 2046, 10.1016/j.celrep.2013.05.028 · DOI
  64. Hamard, 2013, The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo, Genes Dev., 27, 1868, 10.1101/gad.224386.113 · DOI
  65. Krummel, 2005, The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation, Proc. Natl. Acad. Sci. U.S.A., 102, 10188, 10.1073/pnas.0503068102 · DOI · Paper page
  66. Liu, 2007, The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development, J. Pathol., 213, 360, 10.1002/path.2238 · DOI
  67. Abbas, 2010, Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity, Cell Stem Cell, 7, 606, 10.1016/j.stem.2010.09.013 · DOI
  68. Mendrysa, 2003, Mdm2 is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation, Mol. Cell Biol., 23, 462, 10.1128/MCB.23.2.462-473.2003 · DOI · Paper page
  69. Wang, 2011, Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity, Genes Dev., 25, 1426, 10.1101/gad.2024411 · DOI · Paper page
  70. Chan, 2006, Ubiquitination of p53 at multiple sites in the DNA-binding domain, Mol. Cancer Res., 4, 15, 10.1158/1541-7786.MCR-05-0097 · DOI
  71. Tsvetkov, 2010, Ubiquitin-independent p53 proteasomal degradation, Cell Death Differ., 17, 103, 10.1038/cdd.2009.67 · DOI
  72. Gu, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  73. Anderson, 1997, Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation, Mol. Cell Biol., 17, 6255, 10.1128/MCB.17.11.6255 · DOI
  74. Luo, 2004, Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo, Proc. Natl. Acad. Sci. U.S.A., 101, 2259, 10.1073/pnas.0308762101 · DOI · Paper page
  75. Ito, 2001, p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2, EMBO J., 20, 1331, 10.1093/emboj/20.6.1331 · DOI · Paper page
  76. Thompson, 2004, Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis, J. Biol Chem., 279, 53015, 10.1074/jbc.M410233200 · DOI · Paper page
  77. Cesková, 2006, On the mechanism of sequence-specific DNA- dependent acetylation of p53: the acetylation motif is exposed upon DNA binding, J. Mol. Biol., 357, 442, 10.1016/j.jmb.2005.12.026 · DOI
  78. Rajagopalan, 2010, Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms, Nucleic Acids Res., 38, 893, 10.1093/nar/gkp1041 · DOI
  79. van Dieck, 2009, Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53, J. Mol. Biol., 394, 922, 10.1016/j.jmb.2009.10.002 · DOI
  80. An, 2004, Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53, Cell, 117, 735, 10.1016/j.cell.2004.05.009 · DOI · Paper page
  81. Wu, 2013, Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting, Mol. Cell, 49, 843, 10.1016/j.molcel.2012.12.006 · DOI · Paper page
  82. Wu, 2014, Phosphorylation of p53 by TAF1 inactivates p53- dependent transcription in the DNA damage response, Mol. Cell, 53, 63, 10.1016/j.molcel.2013.10.031 · DOI
  83. Todeschini, 2014, Transcription factors: specific DNA binding and specific gene regulation, Trends Genet., 30, 211, 10.1016/j.tig.2014.04.002 · DOI · Paper page
  84. Lee, 2013, Transcriptional regulation and its misregulation in disease, Cell, 152, 1237, 10.1016/j.cell.2013.02.014 · DOI · Paper page
  85. Dunker, 2000, Intrinsic protein disorder in complete genomes, Genome Inform. Ser. Workshop Genome Inform., 11, 161
  86. Mészáros, 2007, Molecular principles of the interactions of disordered proteins, J. Mol. Biol., 372, 549, 10.1016/j.jmb.2007.07.004 · DOI · Paper page
  87. Vacic, 2007, Characterization of molecular recognition features, MoRFs, and their binding partners, J. Proteome Res., 6, 2351, 10.1021/pr0701411 · DOI · Paper page

Cited by

See all 82

Metadata

Authors
Laptenko, O., Tong, D. R., Manfredi, J., & Prives, C.
Venue
Trends in Biochemical Sciences
Publisher
Elsevier BV
Published
2016-12
Volume
41
Issue
12
Pages
1022-1034
ISSN
0968-0004
Cited by
82
References
16
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. https://app.cochat.ai/papers/10.1016/j.tibs.2016.08.011
The paper
Laptenko, O., Tong, D. R., Manfredi, J., & Prives, C. (2016). The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. Trends in Biochemical Sciences. https://doi.org/10.1016/j.tibs.2016.08.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.